The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice

Vaccine

Volumn 28, Issue 48, 2010, Pages 7676-7682

  Fraternale, Alessandra ^a   Paoletti, Maria Filomena ^a   Dominici, Sabrina ^a   Caputo, Antonella ^b   Castaldello, Arianna ^b   Millo, Enrico ^c   Brocca Cofano, Egidio ^b   Smietana, Michaël ^d   Clayette, Pascal ^e   Oiry, Joël ^d   Benatti, Umberto ^c   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITÉ DE MONTPELLIER   (France)

^e SPI BIO   (France)

Author keywords

Macrophage redox state; Pro GSH molecules; Th1 Th2 responses

Indexed keywords

ACETYLCYSTEINE; CYTOKINE; GAMMA INTERFERON; GLUTATHIONE; GLUTATHIONE C4; I 152; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; MERCAPTAMINE; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OOCYTE; OVARIECTOMY; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; CELLS, CULTURED; FEMALE; GLUTATHIONE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; OVALBUMIN; OXIDATION-REDUCTION; SULFHYDRYL COMPOUNDS; TH2 CELLS;

EID: 78249267565     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.033     Document Type: Article

References (38)

1. Masella R., Mazza G. Glutathione and sulfur amino acids in human health and disease 2009, Wiley Inc. Publication.
2. Townsend D.M., Kenneth D.T., Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003, 57(3-4):145-155.
3. Franco R., Schoneveld O.J., Pappa A., Panayiotidis M.I. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007, 113(4-5):234-258.
4. Fraternale A., Paoletti M.F., Casabianca A., Nencioni L., Garaci E., Palamara A.T., et al. GSH and analogs in antiviral therapy. Mol Aspects Med 2009, 30(1-2):99-110.
5. Pace G.W., Leaf C.D. The role of oxidative stress in HIV disease. Free Radic Biol Med 1995, 19(4):523-528.
6. Herzenberg L.A., De Rosa S., Dubs J.G., Roederer M., Anderson M.T., Ela S.W. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 1997, 94(5):1967-1972.
7. Eylar E., Rivera-Quinones C., Molina C., Báez I., Molina F., Mercado C.M. N-acetylcysteine enhances T cell functions and T cell growth in culture. Int Immunol 1993, 5(1):97-101.
8. Murata Y., Shimamura T., Hamuro J. The polarization of T(h)1 T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 2002, 14(2):201-212.
9. Fraternale A., Paoletti M.F., Casabianca A., Oiry J., Clayette P., Vogel J.U., et al. Antiviral and immunomodulatory properties of new pro-glutathione (GSH) molecules. Curr Med Chem 2006, 13(15):1749-1755.
10. Kelly G.S. Clinical applications of N-acetylcysteine. Altern Med Rev 1998, 3(2):114-127.
11. Palamara A.T., Brandi G., Rossi L., Millo E., Benatti U., Nencioni L., et al. New synthetic glutathione derivatives with increased antiviral activities. Antivir Chem Chemother 2004, 15(2):83-91.
12. Oiry J., Mialocq P., Puy J.Y., Fretier P., Dereuddre-Bosquet N., Dormont D., et al. Synthesis and biological evaluation in human monocyte-derived macrophages of N-(N-acetyl-l-cysteinyl)-S-acetylcysteamine analogues with potent antioxidant and anti-HIV activities. J Med Chem 2004, 47(7):1789-1795.
13. Dobashi K., Aihara M., Araki T., Shimizu Y., Utsugi M., Iizuka K., et al. Regulation of LPS induced IL-12 production by IFN-gamma and IL-4 through intracellular glutathione status in human alveolar macrophages. Clin Exp Immunol 2001, 124(2):290-296.
14. Beutler E. Red cell metabolism. A manual of biochemical methods 1984, 131-133. USA Press, New York. Grune, Stratton (Eds.).
15. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969, 27(3):502-522.
16. Gavioli R., Cellini S., Castaldello A., Voltan R., Gallerani E., Gagliardoni F., et al. The Tat protein broadens T cell responses directed to HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS. Vaccine 2008, 26(5):727-737.
17. Liu X., Wetzler L., Massari P. The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant. Vaccine 2008, 26(6):786-796.
18. Lefeber D.J., Benaissa-Trouw B., Vliegenthart J.F., Kamerling J.P., Jansen W.T., Kraaijeveld K., et al. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines protein related to Streptococcus pneumoniae type 3. Infect Immun 2003, 71(12):6915-6920.
19. Germann T., Rude E., Schmitt E. The influence of IL12 on the development of Th1 and Th2 cells and its adjuvant effect for humoral immune responses. Res Immunol 1995, 146(7-8):481-486.
20. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998, 8(3):275-283.
21. Germann T., Bongartz M., Diugonska H., Hess E., Schmitt E., Kolbe L., et al. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur J Immunol 1995, 25(3):823-829.
22. + T cell responses: the alternative approaches. Annu Rev Immunol 1997, 15:297-322.
23. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003, 8(3):223-246.
24. Short S., Merkel B.J., Caffrey R., McCoy K.L. Defective antigen processing correlates with a low level of intracellular glutathione. Eur J Immunol 1996, 26(12):3015-3020.
25. Frosch S., Bonifas U., Eck H.P., Bockstette M., Droege W., Rüde E., et al. The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level intracellular reducing thiols. Eur J Immunol 1993, 23(7):1430-1434.
26. Peterson J.D., Herzenberg L.A., Vasquez K., Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA 1998, 95(6):3071-3076.
27. Murata Y., Amao M., Hamuro J. Sequential conversion of the redox status of macrophages dictates the pathological progression of autoimmune diabetes. Eur J Immunol 2003, 33(4):1001-1011.
28. Murata Y., Shimamura T., Tagami T., Takatsuki F., Hamuro J. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol 2002, 2(5):673-689.
29. Kim H.J., Barajas B., Chan R.C., Nel A.E. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence. J Allergy Clin Immunol 2007, 119(5):1225-1233.
30. Agrawal A., Kaushal P., Agrawal S., Gollapudi S., Gupta S. Thimerosal induces Th2 responses via influencing cytokine secretion by human dendritic cells. J Leuk Biol 2006, 81(2):474-482.
31. Koike Y., Hisada T., Utsugi M., Ishizuka T., Shimizu Y., Ono A., et al. Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am J Respir Cell Mol Biol 2007, 37(3):322-329.
32. Gallo R.C. Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine. Proc Natl Acad Sci USA 1999, 96(15):8324-8326.
33. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993, 67(1):277-287.
34. Caputo A., Gavioli R., Bellino S., Longo O., Tripiciano A., Francavilla V., et al. HIV-1 tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development. Int Rev Immunol 2009, 28(5):285-334.
35. Fanales-Belasio E., Moretti S., Fiorelli V., Tripiciano A., Pavone Cossut M.R., Scoglio A., et al. HIV-Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. J Immunol 2009, 182(5):2888-2897.
36. Wesa A.K., Galy A. IL-1β induces dendritic cells to produce IL-12. Int Immunol 2001, 13(8):1053-1061.
37. Nakae S., Iwakura Y., Suto H., Galli S.J. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leuk Biol 2007, 81(5):1258-1268.
38. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278(3):1910-1914.